What is it about?
Multiple myeloma is one of the most frequent hematologic malignancies. Great improvement in diagnostic tools and therapeutics strategies have led to substantial increase in response rates and survival. Reports of real world data on MM in latin america is scarce. This article shows data from newly diagnosed MM in Uruguay in a recent period
Featured Image
Read the Original
This page is a summary of: From guidelines to real world: results from the National Multiple Myeloma Registry in Uruguay on 222 newly diagnosed multiple myeloma patients from 2012 to 2015, Current Medical Research and Opinion, January 2019, Taylor & Francis,
DOI: 10.1080/03007995.2019.1568091.
You can read the full text:
Contributors
The following have contributed to this page
